Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection.

We investigated the intracellular glutathione redox status in isolated lymphocyte subpopulations and monocytes in patients with human immunodeficiency virus type 1 (HIV-1) infection and in healthy controls. CD4+ lymphocytes from HIV-1-infected patients were primarily characterized by a substantial increase in oxidized glutathione levels and a considerable decrease in the ratio of reduced to total glutathione, in most cases below 0.5 in patients with symptomatic HIV-1 infection, rather than decreased levels of reduced glutathione. The increase in oxidized glutathione was strongly correlated with low numbers of CD4+ lymphocytes in peripheral blood and impaired stimulated interleukin-2 production and proliferation in peripheral blood mononuclear cells, which is compatible with an immunopathogenic role for these redox disturbances. The HIV-1-infected patients with the most advanced clinical and immunologic disease were also characterized by an increase in levels of reduced glutathione in monocytes, suggesting that the glutathione redox cycle may be differentially regulated in CD4+ lymphocytes and monocytes. We could not confirm previous reports suggesting cysteine deficiency as a major cause of disturbed glutathione homeostasis during HIV-1 infection. The demonstrated glutathione abnormalities were correlated with raised serum levels of tumor necrosis factor alpha. These findings suggest that a therapeutical approach, which can restore the glutathione redox dysbalance in CD4+ lymphocytes and decrease the inflammatory stress, may be worthwhile exploring in HIV-1 infection.

[1]  G. Schieven,et al.  Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. , 1994, Journal of immunology.

[2]  K. Schulze-Osthoff,et al.  Functions of glutathione and glutathione disulfide in immunology and immunopathology , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  J. Ameisen Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. , 1994, AIDS.

[4]  D. Bredesen,et al.  INVITED COMMENTARY IS APOPTOSIS MEDIATED BY REACTIVE OXYGEN SPECIES , 1994 .

[5]  Glen,et al.  Changes in plasma amino acid concentrations in response to HIV-1 infection. , 1994, Clinical chemistry.

[6]  Staal,et al.  Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Meister Glutathione-ascorbic acid antioxidant system in animals. , 1994, The Journal of biological chemistry.

[8]  J. V. D. van der Meer,et al.  Monochlorobimane does not selectively label glutathione in peripheral blood mononuclear cells. , 1994, Analytical biochemistry.

[9]  N. Liabakk,et al.  Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters , 1994 .

[10]  S. Jenkinson,et al.  Induction of intracellular glutathione in alveolar type II pneumocytes following BCNU exposure. , 1994, The American journal of physiology.

[11]  T. Buttke,et al.  Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency. , 1994, The Journal of biological chemistry.

[12]  T. Buttke,et al.  Oxidative stress as a mediator of apoptosis. , 1994, Immunology today.

[13]  A. Yamauchi,et al.  Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. , 1993, Journal of immunology.

[14]  D. Rabier,et al.  Intra- and interlaboratory quality control for assay of amino acids in biological fluids: 14 years of the French experience. , 1993, Clinical chemistry.

[15]  F. Piétri-Rouxel,et al.  Thiol reagents increase the affinity of the inositol 1,4,5-trisphosphate receptor. , 1993, The Journal of biological chemistry.

[16]  K. A. Balasubramanian,et al.  Effect of oxidant exposure on thiol status in the intestinal mucosa. , 1993, Biochemical pharmacology.

[17]  H. Masutani,et al.  Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients. , 1992, AIDS research and human retroviruses.

[18]  B. Lauterburg,et al.  Glutathione depletion in HIV‐infected patients: role of cysteine deficiency and effect of oral N‐acetylcysteine , 1992, AIDS.

[19]  A. Malik,et al.  Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. , 1992, The Journal of clinical investigation.

[20]  P. Ueland,et al.  Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. , 1992, Analytical biochemistry.

[21]  M. Roederer,et al.  N-acetylcysteine: a new approach to anti-HIV therapy. , 1992, AIDS research and human retroviruses.

[22]  M. Roederer,et al.  Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. , 1992, AIDS research and human retroviruses.

[23]  M. Schrappe,et al.  T4+ cell numbers are correlated with plasma glutamate and cystine levels: association of hyperglutamataemia with immunodeficiency in diseases with different aetiologies. , 1992, International immunology.

[24]  W. Dröge,et al.  HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acetylcysteine. , 1992, Immunology today.

[25]  M. Roederer,et al.  CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses , 1991 .

[26]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[27]  C. Cross,et al.  Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome. Sense or speculation? , 1991, Archives of internal medicine.

[28]  M. Roederer,et al.  Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Ueland,et al.  Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. , 1990, Analytical biochemistry.

[30]  E. Smeland,et al.  Functional properties of CD19 B lymphocytes positively selected from buffy coats by immunomagnetic separation , 1990, European journal of immunology.

[31]  A. Holmgren,et al.  Thioredoxin and glutaredoxin systems. , 2019, The Journal of biological chemistry.

[32]  R. Crystal,et al.  SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.

[33]  N. Voelkel,et al.  Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor. , 1989, The American journal of physiology.

[34]  B. Fanburg,et al.  Regulation of cellular glutathione. , 1989, The American journal of physiology.

[35]  W. Dröge,et al.  Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. , 1989, Biological chemistry Hoppe-Seyler.

[36]  R. Munday,et al.  Toxicity of thiols and disulphides: involvement of free-radical species. , 1989, Free radical biology & medicine.

[37]  A. Meister Glutathione metabolism and its selective modification. , 1988, The Journal of biological chemistry.

[38]  E. Thorsby,et al.  Direct immunomagnetic quantification of lymphocyte subsets in blood. , 1988, Clinical and experimental immunology.

[39]  D. Ross Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. , 1988, Pharmacology & therapeutics.

[40]  W. Dröge,et al.  Abnormal amino-acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect. , 1988, Biological chemistry Hoppe-Seyler.

[41]  W. Dröge,et al.  Glutathione augments the activation of cytotoxic T lymphocytes in vivo. , 1986, Immunobiology.

[42]  H. Wedner,et al.  The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. , 1985, Journal of immunology.

[43]  S. Orrenius,et al.  Demonstration and partial characterization of glutathione disulfide-stimulated ATPase activity in the plasma membrane fraction from rat hepatocytes. , 1985, The Journal of biological chemistry.

[44]  D. Ziegler Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. , 1985, Annual review of biochemistry.

[45]  C. Krishnamurti,et al.  Application of reversed-phase high-performance liquid chromatography using pre-column derivatization with o-phthaldialdehyde for the quantitative analysis of amino acids in adult and fetal sheep plasma, animal feeds and tissues. , 1984, Journal of chromatography.

[46]  T. Waldmann,et al.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. , 1981, Journal of immunology.